09:56 AM EST - ProMetic Life Sciences Inc. : reported revenues of $6.0 million and an EBITDA loss of $2.0 million for the third quarter ended September 30, 2013. 2013 year-to-date revenues totaled $15.6 million compared to $15.0 million for the same 2012 period. ProMetic Life Sciences Inc.
shares T.PLI are trading down $0.05 at $0.79.
